Financial Performance (FY 2025-26)

  • Turnover: ₹9,06,698 (Previous Year: ₹6,50,710)
  • Other Income: ₹15,81,935 (including ₹12.33 lakh gain on sale of land)
  • Total Income: ₹24,88,633 (PY: ₹8,73,810)
  • Loss Before Tax: ₹(4,52,339) (PY: ₹(12,20,960))
  • Tax Expense: ₹0 (No current tax, deferred tax, or wealth tax)
  • Net Loss: ₹(4,52,339) (PY: ₹(12,20,960))
  • EPS (Basic & Diluted): ₹(0.30) per share (PY: ₹(0.41))

Key Financial Position (as at 31 March 2026)

  • Equity Share Capital: ₹150.05 lakh (reduced from ₹300.09 lakh)
  • Other Equity: ₹(52.79) lakh
  • Total Assets: ₹168.20 lakh (PY: ₹219.13 lakh)
  • Trade Receivables: ₹86.30 lakh (unchanged from PY)
  • Cash & Cash Equivalents: ₹48.78 lakh (PY: ₹48.70 lakh)
  • Loans from Related Parties: ₹30.06 lakh (non-current)

Annual General Meeting Details

  • Date: 24 September 2026
  • Time: 10:00 AM
  • Mode: Video Conferencing (VC) / Other Audio-Visual Means (OAVM)

Agenda Items

Ordinary Business

1. Adoption of audited financial statements for FY 2025-26

2. Re-appointment of Mrs. Pravinaben Gohil (DIN: 0009279658) who retires by rotation

Special Business

3. Appointment of Mr. Soham Ashokkumar Solanki (DIN: 11818073) as Independent Director for 5 years

  • Appointed as Additional Director from 16 July 2026
  • Qualifications: Diploma in Automobile, 5 years technical expertise
  • Not director in any other company

4. Appointment of Mr. Umang Ashwinbhai Shah (DIN: 09735002) as Independent Director for 5 years

  • Appointed as Additional Director from 16 July 2026
  • Qualifications: B.Pharm, 14 years finance and taxation experience
  • Serves as Independent Director of Aashka Hospitals Limited and chairs its committees

Capital Reduction

  • Special resolution passed at EGM on 27 March 2025 for Scheme of Reduction of Capital
  • NCLT approval received on 31 October 2025
  • Implemented through consolidation of equity shares from ₹5 to ₹10 face value
  • Equity share capital reduced from ₹300.09 lakh to ₹150.05 lakh
  • Company relisted on BSE on 34 July 2026 [date appears typographical]

Board of Directors

  • Mr. Devang P Shah (Managing Director, DIN: 00633868)
  • Smt. Pravinaben Gohil (Director, DIN: 0009279658)
  • Mr. Ashok Solanki (Independent Director, DIN: 06803425)
  • Mr. Hiren Mehta (Independent Director, DIN: 06804450)
  • Mrs. Ila Bhagat (CFO)

Auditor Qualifications & Emphasis of Matter

1. Scheme of Reduction of Capital subject to NCLT approval (now obtained)

2. Non-compliance with Companies (Accounts) Rules, 2014 Rule 3(1) regarding audit trail feature in accounting software

3. Trade receivables, trade payables, loans, and advances subject to confirmation and reconciliation

4. No internal audit system established as required u/s 138 of Companies Act

Other Significant Disclosures

  • Business: Trading of food products (mainly milk) and supplying raw material to dairies
  • Shareholding Pattern: Promoters hold 39.31% (Devang Shah 19.49%, Mandakini D Shah 16.75%, Ila Bhagat 3.07%)
  • Dividend: No dividend recommended for FY26
  • CSR: Not applicable as per Section 135 of Companies Act
  • Deposits: No deposits accepted during the year
  • Related Party Transactions: Loans taken from directors amounting to ₹30.06 lakh
  • Managerial Remuneration: ₹6 lakh paid to executive directors
  • Board Meetings: 5 meetings held during FY26

Voting Information

  • Record Date: 19 September 2026
  • Remote e-Voting Period: 21 September 2026 (9:00 AM) to 23 September 2026 (5:00 PM)
  • E-Voting Service Provider: National Securities Depository Limited (NSDL)
  • Instructions: Detailed voting procedures provided for demat and physical shareholders

#Tags: #GoldCoinHealthFoods #SEBIDisclosure #AnnualReport #FY2026Results #AGM2026 #RegulatoryCompliance #FinancialUpdate #Neutral